Jessica S. Merlin

Jessica S. Merlin

Auto-generated profile, based on publicly available information

Jessica S. Merlin

Division of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2023 in American Journal of Hospice and Palliative Medicine®
Verified
Journal Article
Open access
AOAmy O’REgan
Amy O’REgan
LFLaura Jane Fish
Laura Jane Fish
CMChristina Makarushka
Christina Makarushka
TSTamara J. Somers
Tamara J. Somers
KJKatie Fitzgerald Jones
Katie Fitzgerald Jones
DCDevon Check
Devon Check
Objectives: Many cancer survivors experience chronic pain after completing curative-intent treatment. Based on available data, chronic pain may be undertreated in this context; however, little is known about cancer survivors’ experiences with clinical management of chronic pain. The purpose of this study was to better understand cancer survivors’ pain management experiences after curative-intent treatment. Methods: We conducted 13 semi-structured interviews with a convenience sample of cancer survivors who had completed treatment for stage I-III breast, head/neck, lung or colorectal cancer. We used a thematic approach to qualitative data analysis. Results: Participants described that chronic pain often goes unrecognized by their providers, potentially due to limitations in how pain is assessed clinically and the tendency of both cancer survivors and providers to minimize or invalidate the pain experience. To improve communication, participants suggested that providers ask more open-ended questions about their pain, help them to establish functional goals, and provide patients with options for pain management. Significance of Results: This study demonstrates the importance of provider-initiated communication around pain management for cancer survivors to make them feel more supported in their care. Communication and shared decision-making interventions may improve cancer survivor-provider communication around chronic pain management, addressing an important gap in survivorship care.

22 March 2021 in AIDS Care
Verified
Journal Article
Closed access
JMJessica S. Merlin
Jessica S. Merlin
MHM. Hamm
M. Hamm
FCF. de Abril Cameron
F. de Abril Cameron
VBV. Baker
V. Baker
DBD. A. Brown
D. A. Brown
BGB. R. Goodin
B. R. Goodin
Chronic pain is a common comorbidity in people with HIV (PWH), with prevalence estimates of 25-85%. Research in this area is growing, but significant gaps remain. A Global Task Force of HIV experts was organized to brainstorm a scientific agenda and identify measurement domains critical to advancing research in this field. Experts were identified through literature searches and snowball sampling. Two online questionnaires were developed by Task Force members. Questionnaire 1 asked participants to identify knowledge gaps in the field of HIV and chronic pain and identify measurement domains in studies of chronic pain in PWH. Responses were ranked in order of importance in Questionnaire 2, which was followed by a group discussion. 29 experts completed Questionnaire 1, 25 completed Questionnaire 2, and 21 participated in the group. Many important clinical and research priorities emerged, including the need to examine etiologies of chronic pain in PWH. Pain-related measurement domains were discussed, with a primary focus on domains that could be assessed in a standardized manner across various cohorts that include PWH in different countries. We collaboratively identified clinical and research priorities, as well as gaps in standardization of measurement domains, that can be used to move the field forward.

30 March 2018 in Pain Medicine
Verified
Journal Article
Open access
PDF file
MBMarcus A Bachhuber
Marcus A Bachhuber
BSBrendan Saloner
Brendan Saloner
MLMarc LaRochelle
Marc LaRochelle
JMJessica S Merlin
Jessica S Merlin
BMBrandon C Maughan
Brandon C Maughan
SMSean M Murphy
Sean M Murphy
Prescription drug monitoring programs (PDMPs) enable prescribers to review patient prescription histories, and their use is mandatory in many states. We estimated the cost of physicians retrieving PDMP patient reports compared with a model where a delegate (i.e., administrative staff) retrieves reports. We performed a cost analysis with a one-year time horizon, from the perspective of physicians’ employers. We obtained specialty-specific estimates of controlled substance prescribing frequency from the National Ambulatory Medical Care Survey, 2012–2014. We defined three PDMP usage cases based on the frequency of queries: comprehensive (before every Schedule II–IV controlled substance prescription), selective (before new Schedule II–IV prescriptions and every six months for continuing medications), and minimal (before new Schedule II or III prescriptions and annually for continuing medications). The delegate model was less costly for all specialties in the comprehensive usage case and most specialties in the selective usage case, and it was similar to physician model costs in the minimal usage case. Estimated annual costs of the physician model to a large health care system (1,000 full-time equivalent physicians) were $1.6 million for comprehensive usage, $1.1 million for selective usage, and $645,313 for minimal usage. The delegate model was less costly in the comprehensive (savings of $907,283) and selective usage cases (savings of $156,216). Relying on delegates vs physicians to retrieve reports is less costly in most cases. Automation and integration of PDMP data into electronic health records may reduce costs further. Physicians, health care systems, and states should collaborate to streamline access to PDMPs.

10 May 2022 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
JHJiunling Janet Ho
Jiunling Janet Ho
KJKatie Fitzgerald Jones
Katie Fitzgerald Jones
ZSZachary Sager
Zachary Sager
KNKyle Neale
Kyle Neale
JCJulie W. Childers
Julie W. Childers
JMJessica S. Merlin
Jessica S. Merlin

1 October 2019 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
JMJessica S. MD Merlin
Jessica S. MD Merlin
JSJeffrey H. Md Samet
Jeffrey H. Md Samet
DCDebbie M. ScD Cheng
Debbie M. ScD Cheng
MLMarlene C. Ba Lira
Marlene C. Ba Lira
JTJudith I. Tsui
Judith I. Tsui
JLJane M. Liebschutz
Jane M. Liebschutz
Background: Medical marijuana is legal in 29 US states and the District of Columbia: both HIV and chronic pain are “approved conditions” for receipt. Chronic pain is common among people living with HIV (PLWH). We anticipate PLWH will question their providers about medical marijuana for chronic pain. We examined marijuana use and its associations with pain, opioid dose, and HIV viral suppression among PLWH receiving chronic opioid therapy. Methods: PLWH prescribed chronic opioid therapy were recruited into the Targeting Effective Analgesia in Clinics for HIV cohort. The main exposure variable was any past 12-month marijuana use. The primary outcomes were (1) opioid misuse (≥9 on the Current Opioid Misuse Measure) and (2) opioid dose (morphine equivalent daily dose). HIV viral load (VL) suppression (<200 copies/μL) and pain severity and interference using the Brief Pain Inventory were exploratory outcomes. Results: Participants (n = 166) were men (65%), Black (72%), and had an undetectable VL (89%). We found no significant association between current marijuana use and opioid misuse, opioid dose, or pain. Current marijuana use was associated with 3.03 times the odds of having a detectable VL (95% odds ratio: 1.11–8.31, P = 0.03) while controlling for depressive symptoms and other substance use. Discussion: We did not detect an association between marijuana use and opioid misuse behaviors, opioid dose, or pain. In an exploratory analysis, current marijuana use was associated with 3× greater odds of having a detectable VL. This study provides insights into potential consequences of marijuana use among PLWH with chronic pain.

12 November 2024 in Pain
Verified
Journal Article
Open access
KEKarlyn A. Edwards
Karlyn A. Edwards
JMJessica S. Merlin
Jessica S. Merlin
FWFiona Webster
Fiona Webster
SMSean C. Mackey
Sean C. Mackey
BDBeth D. Darnall
Beth D. Darnall